Mar 28, 2023 / 10:30PM GMT
Operator
Thank you for standing by. Welcome to the ImpediMed Limited conference call. (Operator Instructions) I would now like to hand the conference over to Mr. Rick Valencia, Managing Director and CEO. Please go ahead.
Richard P. Valencia - ImpediMed Limited - MD, CEO & Director
Thank you, Rachel. Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our recent announcement related to the NCCN Survivorship guidelines being updated to recommend regular screening for lymphoedema, including the bioimpedance spectroscopy, commonly referred to as BIS.
Joining me on the call today is Tim Cruickshank, Chief Financial Officer; and Frank Vicini. Dr. Vicini is an internationally recognized radiation oncologist. He has extensive experience in cancer clinical trial design and implementation. He is the former Chief Medical Officer of ImpediMed from 2014 to 2022 and remains a dear friend and adviser to the company. Dr. Vicini is currently the Global Chair of Breast Cancer Research and National Director of Breast Cancer Care
ImpediMed Ltd NCCN Investor Update Conference Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
